1-4 of 4
Lisa Forbes
Close
Sort by
Journal Articles

Evaluation of Safety and Efficacy of Ruxolitinib in Patients with Pediatric Lymphoproliferative Disorders

Daria Vakula, Ashley Reiland, Ivan Kingyue Chinn, Sandra Andrea Salinas, Alexander Patlan Nieto, Lisa Forbes Satter, Carl E Allen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2553.
https://doi.org/10.1182/blood-2023-190752
Published: 2023
Journal Articles

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Olive S. Eckstein, MD, Nitya Gulati, MBBS, Lisa Forbes, MD, Erin Peckham-Gregory, PhD MPH, Nmazuo Wudo Ozuah, MBBS, M. Cecilia Poli, MD, PhD, Tiphanie Vogel, Emily M Mace, PhD, Jordan S Orange, MD PhD, Jason Caldwell, D.O., Stephen Jolles, Fracesco Saettini, Hey J Chong, Asbjørg Stray-Pedersen, Helen E. Heslop, MD DSc, Kala Kamdar, MD, Robert A. Krance, MD, Swati Naik, MBBS, Tami D John, MD, Rayne H. Rouce, MD, Donna Muzny, Shalini Jhangiani, Richard Gibbs, Zeynep Coban-Akdemir, James Lupski, Kenneth L. McClain, MD PhD, Carl E. Allen, MD PhD, Ivan Chinn
Journal: Blood
Blood (2019) 134 (Supplement_1): 83.
https://doi.org/10.1182/blood-2019-131884
Published: 2019
Journal Articles

Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome

Roxane Labrosse, MD FRCPC, Julia Chu, MD MPH, Myriam Armant, PhD, Jet van der Spek, MD, Alexandra Miggelbrink, MD, Johnson Fong, John K. Everett, PhD, Hayley Raymond, BA, Lyanna Kessler, Colleen Dansereau, MSN, RN, CPN, Brenda Mackinnon, BSN, RN, Stephanie Koo, Emily Morris, Wendy B. London, PhD, Ahmet Ozen, MD, Safa Baris, MD, Jenny M. Despotovic, DO, MS, Lisa Forbes, MD, Akihiko Saitoh, MD, Takayuki Takachi, MD, Alejandra King, MD, Thi Mai Anh Thi Nguyen, MD, Vy Do Uyen Vu, MD, Frederic D. Bushman, PhD, Anne Galy, PharmD, PhD, Luigi Notarangelo, MD, David A Williams, MD, Sung-Yun Pai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4629.
https://doi.org/10.1182/blood-2019-126161
Published: 2019
Journal Articles

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Joshua D. Milner, Tiphanie P. Vogel, Lisa Forbes, Chi A. Ma, Asbjørg Stray-Pedersen, Julie E. Niemela, Jonathan J. Lyons, Karin R. Engelhardt, Yu Zhang, Nermina Topcagic, Elisha D. O. Roberson, Helen Matthews, James W. Verbsky, Trivikram Dasu, Alexander Vargas-Hernandez, Nidhy Varghese, Kenneth L. McClain, Lina B. Karam, Karen Nahmod, George Makedonas, Emily M. Mace, Hanne S. Sorte, Gøri Perminow, V. Koneti Rao, Michael P. O’Connell, Susan Price, Helen C. Su, Morgan Butrick, Joshua McElwee, Jason D. Hughes, Joseph Willet, David Swan, Yaobo Xu, Mauro Santibanez-Koref, Voytek Slowik, Darrell L. Dinwiddie, Christina E. Ciaccio, Carol J. Saunders, Seth Septer, Stephen F. Kingsmore, Andrew J. White, Andrew J. Cant, Sophie Hambleton, Megan A. Cooper
Journal: Blood
Blood (2015) 125 (4): 591–599.
https://doi.org/10.1182/blood-2014-09-602763
Published: 2015
Includes: Supplemental data